Explore our collection of health and pharma advertising resources.
New HealthFirst™ FAST offering scales access to verified patients and providers across top streaming publishers and platforms including LG Ad Solutions, Pluto TV, and more NEW YORK, August 21, 2025 — DeepIntent, the leading healthcare advertising platform, today announced the release of its HealthFirst™ FAST (Free Ad Supported Streaming TV) Package, a performance-driven solution delivering […]
HCPs are 115% more likely to watch Connected TV than the general population. Streaming is now the front door to HCP engagement. This playbook shows you exactly how to use CTV to reach them with scale, precision, and measurable impact. What you’ll learn: Where and how to connect with HCPs through CTV and complementary OLV strategies. […]
NEW YORK, March 25, 2025 — DeepIntent, the leading healthcare advertising technology company, today introduced DeepIntent Cortex, its most advanced demand side platform (DSP) upgrade to date. Inspired by the human brain’s ability to process complex information, DeepIntent Cortex seamlessly integrates artificial intelligence (AI) with real-time media buying and daily-refreshed health data, delivering an intuitive, […]
What’s the secret to improving your reach, optimizing campaign performance, and driving better health outcomes for consumers today? It’s simple: Health IntelligenceTM. By combining real-time data, artificial intelligence (AI), and programmatic advertising, Health Intelligent campaigns deliver more personalized and relevant health engagements with unmatched speed. As we enter a new era of healthcare advertising, Health […]
NEW YORK, December 20, 2024 — PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, included DeepIntent’s HealthFirst Vaccine Audiences in its annual Innovations Issue, which highlights the most interesting advancements in the life sciences, healthcare, and marketing in 16 categories. HealthFirst Vaccines Audiences was included within […]
NEW YORK, December 5, 2024 — MM+M has announced its sixth class of 40 Under 40 honorees. The program shines a light on the young marketers whose leadership, strategic thinking, and digital facility have contributed to the industry’s continued growth at a challenging time for the healthcare business as a whole. Representing DeepIntent in the […]
Pharma advertising is often understood to promote medications. But does its impact extend further? In partnership with MAGNA Media Trials, we set out to understand whether DTC and HCP audiences consider pharma advertising beneficial. Surveying 1,166 patients and 1,001 doctors, we found that 92% of doctors believe pharma ads empower patients to take a more […]
NEW YORK, October 23, 2024 — DeepIntent, the health advertising platform, has been ranked no.19 by Crain’s New York Business among the 70 Best Places to Work in NYC. The awards program is designed to identify, recognize, and honor the best companies to work for in NYC. In partnership with Workforce Research Group, Crain’s surveyed […]
91% of doctors say pharma advertising improves patient condition awareness and proactive health management NEW YORK, October 10, 2024 — MAGNA, the media intelligence and investment unit of IPG Mediabrands, today announced a new study in partnership with DeepIntent, the health advertising platform, that explores the impact of pharmaceutical advertising beyond its traditional role of […]
Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.
